Biosimilars Cut Cancer Drug Costs by Nearly $4,000 a Month for Insurers, UCLA Study Shows
A UCLA-led analysis of more than 14,000 patient-drug pairs published in JAMA Oncology found that exclusive biosimilar use was associated ...
A UCLA-led analysis of more than 14,000 patient-drug pairs published in JAMA Oncology found that exclusive biosimilar use was associated ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine